In a pivotal recent investigation by Zhang et al.4, it was delineated that CGRP+ nerves support HNSCC cell growth in glucose-deprived conditions, and the blockade of neurogenic CGRP amplifies the potency of anti-glycolysis treatments. Here, CALCA is linked to head and neck squamous cell carcinoma.